IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Opko Health, Inc. SupplierIQ Procurement Profile
OPKO Health, Inc. is a diversified healthcare company engaged in diagnostics and pharmaceutical businesses. It organizes its business into two reportable segments: the Diagnostics segment, which comprise the operations of BioReference, provider of laboratory testing solutions, including, but not limited to, esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units, and the Pharmaceuticals segment, which includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. Its pharmaceutical product portfolio includes, among others, multi-specific immune therapies for oncology, immunology, and infectious diseases; Rayaldee, a patented renal product for the treatment of SHPT in adults with stage 3 or 4 CKD and vitamin D insufficiency; an orally administered selective androgen receptor modulator (SARM) for the potential treatment of the loss of muscle and physical function; Oxyntomodulin for type 2 diabetes and obesity; and a small peptide, carboxyl terminal peptide technology for development of a long-acting CTP-IGF-1 to treat severe primary IGF-1 eficiency. The firm was incorporated in Delaware on November 18, 1991. Its headquarters are located in Miami, Florida.
Access this data your way
The SupplierIQ analysis is available in multiple formats to fit seamlessly into your workflow.
What’s included in this SupplierIQ Profile
IBISWorld's SupplierIQ profile covering Opko Health, Inc. includes financial statements, products & service markets, competitive position and key financial health ratios.
Company Snapshot
What’s covered in this SupplierIQ Profile?
This SupplierIQ profile on Opko Health, Inc. covers the company’s financial statements, products & service markets, competitive position and key financial health ratios. Opko Health, Inc., trading as Opko Health, is a public company with 3.0k employees.
What industries does Opko Health, Inc. operate in?
Opko Health, Inc. primarily operates in Pharmaceutical Preparation Manufacturing, as well as in Diagnostic & Medical Laboratories in the US.
Product & Service Markets
What’s included in the Product & Service Markets chapter?
The Product & Service Markets chapter provides a breakdown of Opko Health, Inc.’s key product and service segments, organized by standardized industry classifications like NAICS. It includes their market share in each of these markets with market share trends and insights.
Competitive Position
What’s included in the Competitive Position chapter?
The Competitive Position chapter covers Opko Health, Inc.’s performance relative to competitors in each of the products and service markets the company operates in. This includes a detailed competitor matrix comparing the market share, return on assets, return on equity, pricing power and competitive outlook. There are qualitative insights and a detailed SWOT analysis included for each product and service market.
Income Statement
What’s included in the Income Statement chapter?
The Income Statement chapter includes datasets covering Opko Health, Inc.’s historical financial performance. Line items include revenue, cost of sales, gross margins, general and administrative costs, research and development costs, depreciation, interest and taxes. This is available in current and historical datasets.
Balance Sheet
What’s included in the Balance Sheet chapter?
The Balance Sheet chapter includes datasets covering Opko Health, Inc.’s historical financial health. Current asset and non-current asset accounts include line items like cash, receivables, inventories, property, plant and equipment, investments, goodwill. Current liabilities and non-current liabilities accounts include line items like accounts payable, debts, provisions and lease liabilities. The equity accounts include line items like paid-in capital, retained earnings, employee stock option plans and treasury stock. This is available in current and historical datasets.
Cash Flows
What’s included in the Cash Flows chapter?
The Cash Flows chapter includes detailed line item accounts covering Opko Health, Inc.’s operating cash flow activities, financing cash flow activities and investing cash flow activities. This is available in current and historical datasets.
Ratios
What’s included in the Ratios chapter?
The Ratios chapter covers key financial metrics like the operating margin, gross margin, return on equity, return on assets, current ratio, quick ratio, EBIT margins, EBITDA margins, debt ratio, equity ratio and debt to equity ratios. This is available in current and historical datasets.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the 2025 revenue for Opko Health, Inc.?
According to the 2026 IBISWorld ProcurementIQ report, Opko Health, Inc. generated $606.9m in revenue.
Who are Opko Health, Inc.’s main competitors?
The 2026 ProcurementIQ report benchmarks Opko Health, Inc. against its top competitors across execution score, operational capabilities, pricing power, and market share.
What is Opko Health, Inc.’s EBITDA margin?
Opko Health, Inc.’s EBITDA margin is reported across a 7-year period in the 2026 IBISWorld ProcurementIQ report. The report includes a full income statement breakdown.
What markets does Opko Health, Inc. operate in?
The 2026 report identifies all NAICS-coded product and service markets Opko Health, Inc. participates in, including market share, concentration, profitability trends, and average vendor risk ratings.
How many employees does Opko Health, Inc. have?
The 2026 ProcurementIQ report lists Opko Health, Inc.’s employee count and benchmarks workforce size against key competitors to assess relative operational capacity.
Cut through the noise with intelligence you can trust
